Notice Type
Consent to the Distribution of Changed Medicines Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto: Schedule Name and Strength Form Name and Address of Manufacturer Proprietary Name(if any) Ipratropium bromide monohydrate 21 mcg equivalent to 20 mcg ipratropium bromide anhydrous per actuation Spray, oral metered dose Boehringer Ingelheim KG., Ingelheim am Rhein, Germany Atrovent Autohaler Ganciclovir sodium 250 mg Capsule Syntex Puerto Rico Inc., Humacao, Puerto Rico Cymevene Lactulose 100% in 10 g, 150 g, 200 g, 350 g, 700 g Powder for oral solution Solvay-Duphar BV., The Netherlands Duphalac Dry Lignocaine 2.5%, prilocaine hydrochloride 2.5% Cream Astra Pharmaceutical Production AB, Sodertalje, Sweden Emla Sterile Cream 5% Estradiol 0.75 mg (delibery rate 25 mcg per day), 1.5 mg (delivery rate 50 mcg per day), 3 mg (delivery rate 100 mcg per day) Transdermal patch Lohmann Therapie Systeme GmbH & Co KG, Andernach, Germany Estraderm MX Fluticasone propionate 50 mcg, 100 mcg, 250 mcg, 500 mcg Powder for oral inhalation Glaxo Operations UK Limited, Ware, Hertfordshire, United Kingdom Flixotide Accuhaler Lenograstim 105 mcg Injection, powder for Chugai Pharmaceutical Co Limited, Utsunomiya, Tochigi, Japan Granocyte 13 Lenograstim 263 mcg Injection, powder for Chugai Pharmaceutical Co Limited, Utsunomiya, Tochigi, Japan Granocyte 34 Human immunoglobulin G 60 mg/mL in 50 mL, 200 mL, 500 mL Injection, solution CSL Limited, Broadmeadows, Victoria, Australia Intragam Tibolone 2.5 mg Tablet Organon International BV., Oss, The Netherlands Livial Gadopentetate dimeglumine 469 mg per mL in 5 mL, 10 mL, 15 mL and 20 mL Injection Schering AG., Berlin, Germany Magnevist Tretinoin 0.05% w/w Cream Cilag AG., Schaffhausen, Switzerland; Johnson & Johnson Medical Products Pty Limited, North Ryde, Sydney, New South Wales, Australia; Ortho Pharmaceuticals Inc., Bo Campo Alegre Manati, Puerto Rico and Ortho Pharmaceuticals Corporation, Raritan, New Jersey, United States of America Retinova Emollient Dated this 14th day of May 1996. HUGH BABER, Assistant General Manager, Health Regulation and Protection, pursuant to delegation given by the Minister of Health on the 18th day of January 1996.
Publication Date
22 May 1996

Notice Number


Page Number